ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,285.34
0.47%
Dow Jones
38,886.17
0.20%
Gold vs US Dollar
2,375.735
0.88%
Brent Oil
79.885
1.69%
Bitcoin
70,673.66
-0.57%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Legend Biotech Corporation (LEGN) Share Price

LEGN Legend Biotech Corporation

46.56
2.92 (6.69%)
After Hours
Last Updated: 21:37:35
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Legend Biotech Corporation NASDAQ:LEGN NASDAQ Depository Receipt  ADS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   2.92 6.69 46.56 42.21 47.50 46.60 43.19 43.83 2,232,541 20:37:35   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 285.14M -518.25M - N/A 
 Type  Size  Price  Time  Units 
 9 1 47.49 21:11:05 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore LEGN News
03/06/202421:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
03/06/202421:00BWLegend Biotech Shares Data on the Earliest Use to Date of CARVYKTI® in the Treatment of Multiple Myeloma and Important Subgroup Analyses at ASCO and EHA
29/05/202413:00BWLegend Biotech to Participate in the Jefferies Global Healthcare Conference
23/05/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
23/05/202422:00BWLegend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
13/05/202412:10IHMARKETNEWSU.S. Futures Climb Amid High Expectations for Inflation Data; Global Markets Show Mixed Reactions
13/05/202412:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Period
Draw mode
Data Downloads for LEGN

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Legend Biotech Corporation Articles